Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 10-20 of  47 results for ""Liver-Specific Organic Anion Transporter 1""

Your Filters

Publication : pharmacogenomics
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Patients carrying CYP2C8*3 have shorter systemic paclitaxel exposure.

  • Authors : Marcath LA; Department of Clinical Pharmacy, University of Michigan College of Pharmacy, Ann Arbor, MI 48109, USA.; Kidwell KM

Subjects: Cytochrome P-450 CYP2C8/Cytochrome P-450 CYP2C8/Cytochrome P-450 CYP2C8/*genetics ; Liver-Specific Organic Anion Transporter 1/Liver-Specific Organic Anion Transporter 1/Liver-Specific Organic Anion Transporter 1/*genetics ; Neoplasms/Neoplasms/Neoplasms/*drug therapy

  • Source: Pharmacogenomics [Pharmacogenomics] 2019 Jan; Vol. 20 (2), pp. 95-104. Date of Electronic Publication: 2018 Dec 06.Publisher: Future Medicine Ltd Country of Publication: England NLM ID: 100897350 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

SLCO1B1 rs4149056 genetic polymorphism predicting methotrexate toxicity in Chinese patients with non-Hodgkin lymphoma.

  • Authors : Yang L; Department of Pharmacy, Fujian Cancer Hospital & Fujian Medical University Cancer Hospital, Fuzhou, China.; Wu H

Subjects: Asian People/Asian People/Asian People/*genetics ; Liver-Specific Organic Anion Transporter 1/Liver-Specific Organic Anion Transporter 1/Liver-Specific Organic Anion Transporter 1/*genetics ; Lymphoma, Non-Hodgkin/Lymphoma, Non-Hodgkin/Lymphoma, Non-Hodgkin/*drug therapy

  • Source: Pharmacogenomics [Pharmacogenomics] 2017 Nov; Vol. 18 (17), pp. 1557-1562. Date of Electronic Publication: 2017 Nov Publisher: Future Medicine Ltd Country of Publication: England NLM ID: 100897350 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

SLCO1A2, SLCO1B1 and SLCO2B1 polymorphisms influences chloroquine and primaquine treatment in Plasmodium vivax malaria.

  • Authors : Sortica VA; Departamento de Genética, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil.; Lindenau JD

Subjects: Chloroquine/Chloroquine/Chloroquine/*therapeutic use ; Liver-Specific Organic Anion Transporter 1/Liver-Specific Organic Anion Transporter 1/Liver-Specific Organic Anion Transporter 1/*genetics ; Malaria, Vivax/Malaria, Vivax/Malaria, Vivax/*genetics

  • Source: Pharmacogenomics [Pharmacogenomics] 2017 Oct; Vol. 18 (15), pp. 1393-1400. Date of Electronic Publication: 2017 Oct Publisher: Future Medicine Ltd Country of Publication: England NLM ID: 100897350 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

The influences of SLCO1B1 and ABCB1 genotypes on the pharmacokinetics of simvastatin, in relation to CYP3A4 inhibition.

  • Authors : Jiang F; Clinical Research Division, National Institute of Food & Drug Safety Evaluation, Ministry of Food & Drug Safety, Cheongju, Republic of Korea.; Choi JY

Subjects: Cytochrome P-450 CYP3A/Cytochrome P-450 CYP3A/Cytochrome P-450 CYP3A/*genetics ; Cytochrome P-450 CYP3A Inhibitors/Cytochrome P-450 CYP3A Inhibitors/Cytochrome P-450 CYP3A Inhibitors/*pharmacokinetics ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/Hydroxymethylglutaryl-CoA Reductase Inhibitors/Hydroxymethylglutaryl-CoA Reductase Inhibitors/*pharmacokinetics

  • Source: Pharmacogenomics [Pharmacogenomics] 2017 Apr; Vol. 18 (5), pp. 459-469. Date of Electronic Publication: 2017 Mar 28.Publisher: Future Medicine Ltd Country of Publication: England NLM ID: 100897350 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Polymorphisms in SLCO1B1 and UGT1A1 are associated with sorafenib-induced toxicity.

  • Authors : Bins S; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Lenting A

Subjects: Polymorphism, Single Nucleotide*; Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*adverse effects ; Glucuronosyltransferase/Glucuronosyltransferase/Glucuronosyltransferase/*genetics

  • Source: Pharmacogenomics [Pharmacogenomics] 2016 Sep; Vol. 17 (14), pp. 1483-90. Date of Electronic Publication: 2016 Aug 17.Publisher: Future Medicine Ltd Country of Publication: England NLM ID: 100897350 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Influx transporter variants as predictors of cancer chemotherapy-induced toxicity: systematic review and meta-analysis.

  • Authors : Zaïr ZM; Warwick Medical School, University of Warwick, Coventry, UK.; Singer DR

Subjects: Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*adverse effects ; Liver-Specific Organic Anion Transporter 1/Liver-Specific Organic Anion Transporter 1/Liver-Specific Organic Anion Transporter 1/*genetics ; Pharmacogenomic Variants/Pharmacogenomic Variants/Pharmacogenomic Variants/*genetics

  • Source: Pharmacogenomics [Pharmacogenomics] 2016 Jul; Vol. 17 (10), pp. 1189-1205. Date of Electronic Publication: 2016 Jul Publisher: Future Medicine Ltd Country of Publication: England NLM ID: 100897350 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

SLCO1B1 variants and the risk of antituberculosis drug-induced hepatotoxicity: a systematic review and meta-analysis.

  • Authors : Zhu M; Department of Epidemiology and Biostatistics, School of Public Health, Nanjing Medical University, Nanjing, 211166, China.; Chen X

Subjects: Genetic Predisposition to Disease* ; Chemical and Drug Induced Liver Injury*/Chemical and Drug Induced Liver Injury*/Chemical and Drug Induced Liver Injury*/epidemiology ; Chemical and Drug Induced Liver Injury*/Chemical and Drug Induced Liver Injury*/Chemical and Drug Induced Liver Injury*/genetics

  • Source: Pharmacogenomics [Pharmacogenomics] 2023 Dec; Vol. 24 (18), pp. 931-942. Date of Electronic Publication: 2023 Nov 29.Publisher: Future Medicine Ltd Country of Publication: England NLM ID: 100897350 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Pharmacogenomic variants affecting efficacy and toxicity of statins in a south Asian population from Sri Lanka.

  • Authors : Ranasinghe P; Department of Pharmacology, Faculty of Medicine, University of Colombo, Colombo 08, Sri Lanka.; University/British Heart Foundation Centre for Cardiovascular Science, The University of Edinburgh, 47 Little France Crescent, Edinburgh, EH16 4TJ, Scotland, UK.

Subjects: Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/adverse effects; Humans ; Pharmacogenomic Variants

  • Source: Pharmacogenomics [Pharmacogenomics] 2023 Oct; Vol. 24 (15), pp. 809-819. Date of Electronic Publication: 2023 Oct 25.Publisher: Future Medicine Ltd Country of Publication: England NLM ID: 100897350 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Associations between SLCO1B1 , APOE and  CYP2C9 and lipid-lowering efficacy and pharmacokinetics of fluvastatin: a meta-analysis.

  • Authors : Zhang ZH; Beijing Shijitan Hospital Affiliated to Capital Medical University, No. 10, Tie Medical Road, Haidian District, Beijing, China.; Yue Sun LC

Subjects: Cholesterol* ; Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use ; Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/pharmacokinetics

  • Source: Pharmacogenomics [Pharmacogenomics] 2023 Jun; Vol. 24 (8), pp. 475-484. Date of Electronic Publication: 2023 Jun 15.Publisher: Future Medicine Ltd Country of Publication: England NLM ID: 100897350 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

The frequency of major ABCG2 , SLCO1B1 and CYP2C9 variants in Asian, Native Hawaiian and Pacific Islander women subgroups: implications for personalized statins dosing.

  • Authors : Alrajeh K; Department of Pharmacotherapy & Outcome Science, Virginia Commonwealth University School of Pharmacy, 410 N 12th Street, Richmond, VA 23298, USA.; Department of Pharmacy Practice, King Faisal University College of Clinical Pharmacy, PO Box 400, Hofuf, Eastern Province, 31982, Saudi Arabia.

Subjects: Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/administration & dosage ; Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/adverse effects ; Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/pharmacokinetics

  • Source: Pharmacogenomics [Pharmacogenomics] 2023 May; Vol. 24 (7), pp. 381-398. Date of Electronic Publication: 2023 May 24.Publisher: Future Medicine Ltd Country of Publication: England NLM ID: 100897350 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
  • 10-20 of  47 results for ""Liver-Specific Organic Anion Transporter 1""